399 related articles for article (PubMed ID: 10651386)
21. Current management strategies for intraocular retinoblastoma.
Kim JW; Abramson DH; Dunkel IJ
Drugs; 2007; 67(15):2173-85. PubMed ID: 17927283
[TBL] [Abstract][Full Text] [Related]
22. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
[TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma in Turkey--treatment and prognosis.
Günalp I; Gündüz K; Arslan Y
Jpn J Ophthalmol; 1996; 40(1):95-102. PubMed ID: 8739506
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Options for Retinoblastoma.
Mendoza PR; Grossniklaus HE
Cancer Control; 2016 Apr; 23(2):99-109. PubMed ID: 27218786
[TBL] [Abstract][Full Text] [Related]
25. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy.
Gallie BL; Budning A; DeBoer G; Thiessen JJ; Koren G; Verjee Z; Ling V; Chan HS
Arch Ophthalmol; 1996 Nov; 114(11):1321-8. PubMed ID: 8906022
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy in Retinoblastoma: Current Approaches.
Yanık Ö; Gündüz K; Yavuz K; Taçyıldız N; Ünal E
Turk J Ophthalmol; 2015 Dec; 45(6):259-267. PubMed ID: 27800245
[TBL] [Abstract][Full Text] [Related]
28. Conservative treatment modalities in retinoblastoma.
Chawla B; Jain A; Azad R
Indian J Ophthalmol; 2013 Sep; 61(9):479-85. PubMed ID: 24104705
[TBL] [Abstract][Full Text] [Related]
29. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
[TBL] [Abstract][Full Text] [Related]
30. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
31. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
32. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
Shields CL; Shields JA
Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
[TBL] [Abstract][Full Text] [Related]
33. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
[TBL] [Abstract][Full Text] [Related]
35. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.
Friedman DL; Krailo M; Villaluna D; Gombos D; Langholz B; Jubran R; Shields C; Murphree L; O'Brien J; Kessel S; Rodriguez-Galindo C; Chintagumpala M; Meadows AT
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28019092
[TBL] [Abstract][Full Text] [Related]
36. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
[TBL] [Abstract][Full Text] [Related]
38. Results of a prospective study for the treatment of retinoblastoma.
Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
[TBL] [Abstract][Full Text] [Related]
39. [ADVANCES IN THE TREATMENT OF RETINOBLASTOMA AT HADASSAH IN THE LAST THREE DECADES].
Frenkel S; Weintraub M; Rot I; Shoshani N; Pe'er J
Harefuah; 2018 Mar; 157(3):149-153. PubMed ID: 29582943
[TBL] [Abstract][Full Text] [Related]
40. [Choroidal melanoma: current therapeutic approaches].
De Potter P
J Fr Ophtalmol; 2002 Feb; 25(2):203-11. PubMed ID: 11941244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
